SCHEMBL2075867

SCHEMBL2075867

O=C(O)c1cc2c([nH]1)CCC2Cc1cc(F)cc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.36
MGLL Q99685 1/20 0.36
METAP2 P50579 3/20 0.33
FFAR4 Q5NUL3 2/20 0.33
CCR3 P51677 1/20 0.33
RHEB Q15382 1/20 0.33
GRIN1 Q05586 2/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
CYP2C19 P33261 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PDPK1 O15530 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
NFKB1 P19838 1/20 0.32
APEX1 P27695 1/20 0.32
HSD17B10 Q99714 1/20 0.32
DAO P14920 2/20 0.32
GRM4 Q14833 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003720 0.87 KMT2A (0.33) FAAHMGLLMETAP2CCR3ALDH1A1
SCHEMBL1004540 0.83 ESR1 (0.41) RHEBHPGDTSHRKDM4ELMNA
SCHEMBL1007006 0.83 ESR1 (0.38) HPGDTSHRCYP2C19TDP1KDM4E
SCHEMBL1004610 0.83 GRM2 (0.39) RHEBESR1ESR2
SCHEMBL1003672 0.82 HCAR2 (0.40) HPGDTSHRCYP2C19TDP1KDM4E
SCHEMBL1005137 0.82 ESR1 (0.42) ALDH1A1LMNAMEN1KMT2AESR1
SCHEMBL2077148 0.82 METAP2 (0.36) FAAHMGLLMETAP2FFAR4CCR3
SCHEMBL1004613 0.81 KDM5A (0.37) RHEBTSHRALDH1A1ESR1ESR2
SCHEMBL1004549 0.79 TPMT (0.34) KDM4EALDH1A1LMNANFKB1ALOX15
SCHEMBL12777445 0.79 DDB1 (0.44) GRIN1HPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE FAAH 402/4885MGLL 2303/4885METAP2 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.